Accès ouvert
2026
article
OpenAlex
Hairong Jing, Dan Yuan, Bangquan Ye, Jianlin Ma et autres
Chimeric antigen receptor T cell therapy (CAR-T) has demonstrated promising efficacy in hematological malignancies, but translating that success to solid tumors remains challenging. Here, we construct a CAR library comprising approximately 1000 variants targeting prostate-specific membrane antigen by recombining transmembrane (TM), co-stimulatory, …
cn
(code pays fourni par la source)
Accès ouvert
2025
dataset
OpenAlex
Hairong Jing, Dan Yuan, Bangquan Ye, Jianlin Ma et autres
Chimeric antigen receptor T cell therapy (CAR-T) has demonstrated promising efficacy in hematological malignancies, but translating that success to solid tumors remains challenging. Here, we construct a CAR library comprising approximately 1,000 variants targeting prostate-specific membrane antigen by recombining transmembrane (TM), co-stimulatory, …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Fangming Wang, Gang Zhang, Tianli Xu, Jianlin Ma et autres
BACKGROUND: Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or Bacillus Calmette-Guérin therapy. However, these treatments have a high recurrence rate and side effects, emphasizing the need for alternative instillations. Previously, …
cn, us
(code pays fourni par la source)
2023
article
OpenAlex
Fangming Wang, Shuai Liu, Fei Liu, Tianli Xu et autres
cn, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Shuang Gao, Yongqiang Jin, Jianlin Ma, Juan Wang et autres
BACKGROUND: Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been widely used due to their multipotency, a broad range of sources, painless collection, and compliance with standard amplification. Cell sheet technology is a tissue engineering methodology requiring scaffolds free, and it provides …
cn, jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Fangming Wang, Xuejiao Dong, Jing Wang, Feiya Yang et autres
Adoptive allogeneic natural killer (NK) cell therapy has shown promise in treating castration-resistant prostate cancer (CRPC), which is the terminal stage of prostate cancer (PCa) and incurable. Thus, we employed an efficient manufacturing method for the large-scale ex vivo expansion of high-quality …
cn, jp
(code pays fourni par la source)